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During early fetal ontogeny in birds, the epithelial thymic rudiment is colonized
by T cell precursors at specific developmentally regulated time intervals (1, 2). Avian
yolk sac, bone marrow, and to a lesser degree, spleen and bursa of fabricius contain
hematopoietic cell precursors that are able to migrate to thymic rudiments and give
rise to T lymphocytes (2, 3).
In vitro studies using embryonic mouse thymic cultures have similarly demon-
strated that hematopoietic cells in fetal yolk sac, bone marrow, and fetal liver can
migrate to and colonize 10-d thymic epithelial rudiments (4, 5). Using avian thymic
rudiment cultures and bone marrow cells, thymic epithelial cell-derived chemotactic
peptides have been defined that are secreted during the time that the thymic microen-
vironment is colonized by T cell precursors (6). Moreover, the phenomenon of avian
thymic rudiment colonization by sequential cohorts of T cell precursors in waves
has been shown to be due to developmentally regulated periods of thymic epithelial
cell production of chemotactic peptides (2, 3, 6).
While it is known that hematopoietic cell precursors are present in embryonic
tissues before periods of thymic rudiment colonization by T cell precursors (1, 7),
little is known regarding the identification via cell marker expressionofT cell precursors
in avian (8) mouse (5, 9, 10) or human (11, 12) fetal tissues before precursor cell
entry into the thymus .
In our previous studies ofone human fetal tissue before hematopoietic cell coloni-
zation of the epithelial thymic rudiment, we identified CD7+, CD45 + (T200 + ) cells
in perithymic mesenchyme, and demonstrated that the CD7 T antigen (13-15) is
the only known T lineage marker expressed on fetal hematopoietic cells before lym-
phoid cell colonization ofthe thymus (16). Moreover, we demonstrated that in man,
the critical window of time for thymic development is between 7 and 14 wk of fetal
gestation (16). This early time of colonization of the human thymus has hampered
both the identification of fetalT cell precursors and the study of early differentiation
events of human T cells.
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Since these initial studies, we have been able to study a large number of early
(7-12 wk) human fetal tissues. The present study was undertaken to identify the
human precursor of the T lymphocyte lineage in fetal tissue using immunohisto-
logic studies on tissue sections with the CD7 monoclonal antibody, and using func-
tional studies of isolated CD7 + fetal cells in vitro. Moreover, we sought evidence
to determine whether a discrete time period of influx of T cell precursors into the
thymic rudiment was present in human fetal ontogeny, as has been demonstrated
in avian systems. We found that CD7+ cells could be identified in fetal liver and
yolk sac from as early as 7 wk of fetal gestation. Moreover, at 7-8 .5 wk of gestation,
CD7` cells were concentrated in mesenchymal areas of upper fetal thorax regions.
Functional studies of CD7' cells from fetal liver and thoracic mesenchyme of early
fetal tissues demonstrated the ability of CD7' cells to proliferate in the presence
of T cell-conditioned media (TCM)' and rIL-2, to form T cell colonies (CFUT)
in vitro, and to be driven in vitro to express markers of mature T cells.
Materials and Methods
Fetal Tissues.
￿
Fetal tissues were obtained as discarded tissue from the pathology depart-
ment, Duke University Medical Center, from either elective first trimester abortions or at
the time of surgery for ectopic pregnancy. Gestational age, determined by crown-rump length,
menstrual records, and fetal part morphology, ranged from 7 to 12 .75 wk (17). In all experi-
ments the region of the body from which the tissue was obtained was identified using a dis-
secting microscope. In number 50 (7 wk), the neck, thorax, and abdomen were serial sec-
tioned at 4 ltm intervals from the liver through the oral cavity. Hematoxylin and eosin stains
were performed on sections every 80 pm (18). In this tissue, the 7-wk epithelial thymic rudi-
ments were identified by their ventral positions relative to the carotid artery and by their
reactivity with thymic epithelial markers TE-4 and A2B5 (18). In tissues 24 (8 wk) and 20
(8 .5 wk), upper thorax was compared with upper extremity for the presence of hematopoietic
cells. In tissues 20 (8.5 wk), 48 (9.5 wk), 2 (10 wk), 22 (10 wk), and 40 (12 .75 wk), upper
thorax tissue was compared, in the studies described below, with thymic tissue. Yolk sac was
available from one tissue (number 19, 7 wk of gestation).
Fetal tissues were divided into 5 mm cubes or smaller, were snap frozen in adry ice/ethanol
slurry, and were stored in liquid nitrogen . Tissue cubes were embedded in OCT Compound
(Lab Tek Products, Naperville, IL), were cut into 4 1LM sections, air-dried, and fixed in cold
acetone (-20°C) for 5 min (18). Tissue sections were either used immediately in indirect
or direct immunofluorescence assays or were stored at - 70°C.
Monoclonal Antibodies.
￿
The specificities of the monoclonal antibodies used in this study
are listed in Table I (13-15, 19-31). Each antibody was used at an optimal saturating concen-
tration as determined from titration experiments using IF assays on tissue sections or IF assays
on cell suspensions using cytofluorography.
IF Assays.
￿
Indirect IF assays were performed on acetone-fixed 4 gm tissue sections as
described (18) using goat anti-mouse Ig (Kirkegaard and Perry, Gaithersburg, MD). In pre-
liminary experiments it was found that acetone fixation of tissue sections either did not de-
crease or slightly increased the reactivity of the monoclonal antibodies in Table I to human
tissues except for antibodies WT31 (24) and BMA031 (25). We found the reactivity of these
two latter antibodies (against the T cell receptor for antigen [Ti] a and R chains) (24, 25)
with human tissues was markedly decreased by fixation oftissues with acetone. Consequently
all experiments using WT31 or BMA031 were performed using nonfixed 4 ltm tissue sec-
' Abbreviations used in this paper: BFU-E, Burst forming unit-erythroid; BM, Bone marrow; rEPO,
recombinant erythopoietin; GEMM, granulocyte, erythroid, megakaryocyte/macrophage; GM, gran-
ulocyte/macrophage; IF, immunofluorescence; PLA, placental conditioned media; 'I'CM, T cell condi-
tioned media; Ti, T cell receptor for antigen.HAYNES ET AL.
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TABLE I
Monoclonal Antibodies Used to Study Fetal Tissues
tions. A recent study has suggested that when high concentrations of antibody WT31 are
used, or after neuraminidase treatment of Tcells, WT31 can weakly bind to framework de-
terminants of the y, S forms of T cell receptors (32). To validate the specificity of WT31 in
this study we demonstrated that, under the conditions used here, antibody WT31 did not
react with Ti8' cells. The saturating binding titer of antibody WT31 was determined on
postnatal thymic tissue sections and on peripheral blood mononuclear cells in suspension
using indirect IF assays. Antibodies WT31 and TCR81 (antiTi6) (26) were next compared
with regard to their reactivity patterns on a series of tissues and cell lines. We found that
TCR81 did not react with WT31' mature T cell lines, and that antibody WT31 did not
react with CD3', T16' normal immature thymocytes in in vitro culture. Postnatal thymus
that contained WT31' medullary zones were essentially all TCR61- using IF assays on
frozen tissue sections. Finally, two 8-wk fetal thorax tissue were found that were WT31- and
contained clusters of TCRS1' cells. Thus, under the conditions used in this study, antibodies
WT31 and TCR81 reacted with mutually exclusive patterns on tissue sections and cell sus-
pensions. Sections stained in IF assays were viewed on a Nikon Optiphot fluorescent micro-
scope. Double IF assays were performed as described previously (18). In several experiments
cell populations grown from thoracic fetal tissue, or cells isolated or grown from fetal liver
tissue were analyzed in indirect IF assays either by staining cytocentrifuge preparations of
cells or by performing indirect IF assays on live cells in suspensions and assaying forantibody
reactivity using a Coulter 753 cytofluorograph.
Cell Culture Methods.
￿
Fetal liveror thorax cellswere cultured in medium (standard medium)
consisting of RPMI 1640 (Gibco, Grand Island, NY) supplemented with 10% horse serum
and 10% heat-inactivated FCS (both from Gibco), nonessential amino acids, 1 mM pyru-
vate, 2 mM glutamine, and penicillin/streptomycin antibiotics in 5% C02 in air at 37°C .
Thawing medium consisted of RPMI 1640 containing 30% heat-inactivated FCS, peni-
cillin/streptomycin antibiotics, heparin 20U/ml, 0.01 mg/mlDNase, and 1,000U/ml Urokinase.
Cluster of
differentiation Representative antibodies Antigen/Specificity
CD1 NAl/34 T6/Cortical Thymocytes
CD2 35.1, OKT11 T11/Sheep erythrocyte
rosette receptor/pan
T cell
CD3 Leu-4, OKT3 T3 antigen associated
with the T cell
receptor for antigen
CD4 Leu-3 T4/helper-inducer T
cells
CD7 3A1 3A1, Tp40/pan T cell
CD8 T8, Leu-2a T8/suppressor T cells
- WT31, BMA031 T cell receptor for
antigen, a and R
chains
- TCR61 T cell receptor for
antigen, 6 chain
CD45 FIO-89-4 T200/pan leukocyte
CD25 TAC p55 IL-2 receptor-
activated T cells
CD11 MO-1 Monocytes/macrophages
CD14 Leu M3 Monocytes/macrophages
- E5 Pan erythrocyte lineage,
glycophorin p1064
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Isolation of CD7' and CD7- Fetal Liver Cell Subsets.
￿
CD7' and CD7 - subsets of fetal
liver cells were obtained by panning techniques as previously described (33) using fetal liver
cells coated with the 3AI A CD7 monoclonal antibody (13) and plastic petrie dishes coated
with goat anti-mouse Ig (Kirkegaard and Perry).
Growth Supplements.
￿
Media conditioned by human peripheral blood T cells (TCM) (ob-
tained by E-rosette separation) for 72 h in the presence of 1 % PHA (34), and placental condi-
tioned medium (PLA) (35) were prepared as described. 5637-conditioned medium (CM)
(36-38) was harvested from a culture ofthe 5637 human bladder carcinoma cell line at 60%
confluence. Conditioned media supernatants were centrifuged at 3,000 g for 30 min, aspi-
rated, and filtered through a 0.22 gm filter, and stored at -70'C until use. Human recom-
binant GM-CSF and IL-3 were kindly provided by Dr. Steven Clark, Genetics Institute,
Cambridge, MA. Human recombinant IL-2 and erythropoietin (rEPO) were purchased from
E. I. Dupont de Nemours and Co., (Glenolden, PA) and Amgen Biologicals, (Thousand Oaks,
CA), respectively.
Morphologic Characterization. Standard 200-cell differential counts were performed on
cytocentrifuge (Shandon II; Shandon Southern Instruments, Inc., Sewickley, PA) prepara-
tions of cells stained with the Difl-Quik modification of the Wright's/Giemsa technique (39).
Differentiation of Fetal Cells in Culture.
￿
Fetal cells were obtained as described and initiated
into suspension culture at a density of 10' cell/ml in a 24-well tissue culture plate (Costar,
Cambridge, MA) in a total volume of 2 ml of standard medium supplemented with either:
10% PLA as a source of GM-CSF (35) or human recombinant GM-CSF (5 U/ml); 10%
5637 CM as a source of G-CSF, GM-CSF, or crude IL-3 (36-38) or human recombinant
IL-3 (5 U/ml), plus rEPO (2 U/ml); 10% TCM plus rIL-2 (80 U/ml); or without additions.
100 ul aliquots ofeach culture were removed weekly, cytocentrifuged, stained with Dif Quik,
and evaluated microscopically. All cultures were expanded as needed with standard medium
plus growth supplements to maintain cell density at 10' cells/ml . Fetal cells were also cul-
tured in semisolid medium to assess the potential of these cells to give rise to committed clonal
hematopoietic progenitors (CFU-GM-C, colony forming unit of granulocyte/macrophage;
CFU-GEMM, CFU of granulocyte/erythrocyte/monocyte/megakaryocyte; BFU-E, burst
forming unit of erythroid cells; CFUT, CFU of T cell). For these assays 10', 5 x 10', and
10' cells were cultured in a base mixture of 0.9% methyl cellulose (1,500 centipoises; Sigma
Chemical Co., St. Louis, MO) containing equal amounts of a-MEM and Iscove's Modified
Dulbecco's Medium (both from Gibco), 12.5% horse serum (Gibco) 12.5% heat-inactivated
FCS (Gibco), and penicillin/steptomycin antibiotics in a total volume of 1 ml in a gridded
plate (Lux, Miles Laboratories, Naperville, IL). To assay GM-CFU-C, 10% placental condi-
tioned medium was added to each culture plate. To assay CFU-GEMM and BFU-E, 1%
deionized BSA (Sigma Chemical Co.), 10- ' 2-ME, 10% 5637 conditioned medium, and 2
U/ml ofhuman recombinant erythropoietin were added to each plate. To assay CFUT, 10%
TCM 80 IJ/ml of rIL-2, and 10' M 2-ME were added to each plate. All samples were cul-
tured in duplicate and maintained at 37'C in a humidified 5% COz in air atmosphere. Colo-
nies were scored on an inverted microscope (Olympus) after 7, 14, and 21 d of culture. Repre-
sentative colonies from each plate were picked, washed, cytocentrifuged and stained with
Wright's-Giemsa and examined microscopically for morphologic confirmation ofcolony com-
position.
Results
Phenotype of Hematopoietic Cells in Human Fetal Yolk Sac, Neck, and Thorax.
￿
Using
expression ofthe CD45 and CD7 antigens as markers of T cell precursors, we studied
11 fetal tissues for the distribution of CD45', CD7+ cells, and determined the
phenotype of these cells with regard to expression of other markers of the T cell
lineage (Table II). We have previously reported in 7-wk fetal tissue, using double
indirect IF assays, that only a subset of fetal CD45' cells are CD7', whereas all
CD7' cells are CD45' (16).
At 7 wk of gestation, before the time of hematopoietic cell colonization of the thymusX
4
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TABLE II
Phenotype of Hematopoietic Cells in Human Fetal Yolk Sac, Neck, and Thorax
- , no cells positive in IF assay.
+ / - , <I0 positive cells per tissue sections.
+, >10 positive cells per tissue sections.
+ + , >5 positive cells per 400x field.
TCR81 is a monoclonal antibody reactive with the 8 chain of the T cell receptor for antigen (26).
WT31 is a monoclonal antibody reactive with the a and 0 chains of the T cell receptor for antigen (24).
Antibody BMA031 ; also against the T cell receptor a and R chains, was also assayed for reactivity against
tissues, with identical results to those shown using WT31 (not shown).
Reactivity of anti-CD4 antibodies with tissue in indirect IF assays identified T200', Leu M3', CD7-
pigment-containing tissue macrophages.
(18, 40), CD7+ cells were present in yolk sac (Fig. 1 A and B), upper thorax (Fig.
1 C) and fetal neck areas. In fetus number 50, we were able to demonstrate that
CD7+ cells were more prevalant in the neck and upper thorax by serial sectioning
through the thymic region (neck and upper thorax) where there were >10 CD7+
cells per tissue section. In many neck and upper thorax areas, there were foci of
10-20 CD7+ cells per 400 x field. 200 tissue sections caudal to the thymic region
(800 pM), the lung buds were located along with the distal esophagus. At this level
of the lower thorax, no CD7+ cells were present. Only scattered CD45+, CD14',
CD7- tissue macrophages were present at the level of the primordial lungs (Fig.
1 D). At 7 wk, in theheart and aorta of number 50, only E5' (glycophorin R+ ) cells
of erythroid lineage (31) were present (Fig. 1 E), with no CD45 +, CD14+, or CD7+
cells seen (Fig. 1 E).
In one (number 35) of four 7-wk thoracic tissues tested, large numbers of CD7+
cells were present throughout mesenchyme (>20 positive cells per 400x field). Un-
like tissues number 19, 46, and 40, where no CD3+, CD8+, or CD2+ cells were seen,
in number 35 upper thorax, rare (<5% of CD7+ cells) CD2+, CD3+, and CD8+
cells were present (Table II).
At 8 and 8.5 wk of gestation, just at the time of hematopoietic cell colonization
of the human thymus (40) (tissue numbers 32, 24, and 20), CD7+ cells were seen
in every field of every neck and upper thorax tissue section (Fig. 2). As with 7 wk
Tissue
number
Gestational
age Source CD45 CD7 CD2 CD3
Marker expression
TCR81` WT31 1 CD8 CD1 CD45
wk
17 7 Yolk sac + + - - - - - - +
46 7 Upper thorax + + - - - - - - +
50 7 Neck + + - - - - - - +
50 7 Upper thorax + + - - - - - - +
50 7 Lower thorax + - - - - - - - +
35 7 Upper thorax + + + + + +/ - - - +/ - - +
35 7 Neck + + + + + +/- - - +/- - +
32 8 Thorax + + + + + - +
24 8 Upper thorax + + + + + + + / - - +/ - - +
20 8.5 Upper thorax + + + + + +/ - - - +/ - - +
48 9.5 Upper thorax + - - - - - - - +
2 10 Neck + - - - - - - - +/-
22 10 Upper thorax + - - - - - - - -
40 12 .75 Upper thorax + - - - - - - - +FIGURE 2 .
￿
CD7' cells are present in mesenchyme of the upper thorax at 8 wk of fetal gesta-
tion . (A) Keratin-positive skin (as defined by antibody AE-1) of 8-wk (number 24) fetal thorax ;
B and Cshow sequential 4-um sections following that seen inA reacted with anti-CD7 antibody
(B) andanti-CD45 antibody (C) . (D and E) Sections of extremity of number 24, with keratin-
positive skin shown in D. In contrast to upper thorax, no CD7* cells were seen in number 24
extremity, as shown in E. (F) Whereas many CD7* and CD45* cells were present in upper
thorax and neck of 8-wk tissue, no CD7* cells (not shown) and rare (arrow) CD45' cells were
present in the 10-wk neck tissue of number 2 . (G) 8-wk number 24 thorax tissue that is nonreac-
tive withWT31 (antiTi a,D). (Hand 1) Intrathorax small vessels (V) in tissue number 24 con-
taining rare CD8' cells (arrows) (H) and CD3' (I) cells (arrows). 400x .
FIGURE 1 .
￿
Phenotype of hematopoietic cells in 7-wk human fetal tissues . (A)Hematoxylin and
eosin-stained section of yolk sac from number 19 . (B) A sequential 4-4m section reacted with
the anti-CD7 antibody, 3AIA , in indirect IF assay . Long arrows point out endoderm of yolk sac
that was weakly autofluorescent in B . Short arrow points out CD7' cell in B and likely
mononuclear cell counterpart inA . Open arrows point out mature granulocytes inA. (C Cluster
ofCD7' cells (arrows) in upper thorax of 7-wk tissue from number 46 . While no CD7' cells
were present at the level of the lung bud in tissue number 50, clusters of CD45' macrophages
(arrow) were present (D). (E) All cells present within aorta at 7 wk were glycophorin 6' erythroid
precursors (arrows) whileD shows that no intravascular cells were Leu-M3' . Arrows point to
Leu-M3- cells . 400x .1068
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tissue number 35, rare CD2', CD3', and CD8' cells were present in all 8- and 8.5-
wk thorax tissues, with cells frequently centered in and around vessels (Fig. 2, H and 1).
To determine if the presence of CD7' cells in the upper thorax of 8- and 8.5-wk
tissue represented regional localization of CD7+ cells in the fetus at this stage of
gestation, other fetal tissues distant from upper thorax (i.e. upper extremity) from
numbers 24 and 20 were sectioned and assayed for the presence of CD7 + cells.
Whereas numbers 24 and 20 upper thoracic regions contained >50 CD7' cells per
400 x field (Fig. 2 B) there were <5 CD7' cells per tissue section ofupper extremity
from these same fetuses (Fig. 2 E). Thus, as with the 7-wk fetus tested (number
50), in 8-8.5-wk fetal tissues, CD7 + cells were concentrated in the upper thorax.
By 9.5 wk (number 48), after hematopoietic cells had colonized the thymus, and
in the older fetal tissues up to 12.75 wk (numbers 2, 22, and 40), no CD7' cells
were present in upper thorax or neck regions (Fig. 2 F and Table II) .
To study T cell receptor expression at the protein level, CD7' cells in 7- and 8-
wk upper thorax areas were assayed for their reactivity with monoclonal antibodies
specific for T cell receptor S chain (TCRS1) (26), and T cell receptor a and R chains
(WT31, BMA031) (24, 25). We found that, in all but two (numbers 24 and 32) tissues
studied, no T18' or Tia, Q' cells were present (Fig . 2 G and Table II) . In 24 and
32 rare Ti6' cells were seen that were also CD3' (Fig. 3). However, most CD3'
cells in 7-8.5-wk tissues were both TCRS1 - and WT31 - .
PhenotypeofHematopoietic Cells in Fetal Thymus.
￿
In our studywe were able to evaluate
the thymus in six fetuses (numbers 50, 20, 48, 2, 22, and 40) (Table II). As previ-
ously reported (16, 18), at 7 wk the epithelial thymus of number 50 contained no
lymphoid or monocytoid cells, and therefore was at a stage prior to the time of any
hematopoietic cell colonization. At 8.5 wk, thymus number 20 contained CD45',
CD4', CD14', macrophages as well as CD7' thymocytes . Using double IF assays
with directly fluoresceinated CD7 antibody and CD14 or CD4 antibodies, we demon-
strated that 8.5-wk CD7' cells were CD4- and CD14 - (not shown). "20 0 /0 of CD7'
cells in thymus at 8.5 wk were CD2' (41). Thus, the first T cell antigen acquired
by CD7' cells after their entry into the epithelial thymic rudiment is CD2. Rare
(<5 cells per tissue section) CD3' cells were also seen in 8 .5-wk thymic tissue. As
previously reported, by 9 .5-10 wk all T cell antigens listed in Table III were ex-
pressed as determined by indirect IF assays (16, 41).
PhenotypeofHematopoietic Cells in FetalLiver.
￿
Many investigators have documented
the presence of T cell precursors in the fetal liver of mice, dogs, and men (4, 5, 9,
10, 42-44). Thus, if the CD7' cell population in fetal tissues contained T cell
precursors, then CD7' cells should be present in fetal liver. We found (Table IV)
that CD7' cells were present in all four fetal livers available for study, with the
phenotype of CD7' fetal liver cells being CD3- , CD8 -, CDl -, CD2-, and CD45'.
As with the majority of upper thorax and neck CD7' cells, CD7' cells in fetal liver
from 7 through 12.75 wk were Ti S- and Ti a, 0 - (Table IV). To determine the
number of CD7' cells in fetal liver tissue, the number of CD7' cells per tissue sec-
tion was counted and expressed per volume oftissue (i.e., section length x width x
width x 4 gm thick). The number of CD7' cells present in fetal liver was at 7 wk
(number 50), 40 cells/mm3 ; 9.5 wk (number 48), 2,708 cells/mm 3; 10 wk (number
22), 1,550 cells/mm 3 ; and 12.75 wk (number 40) 2,650 cells/mm' .
CD7' Fetal Liver Cells Give Rise to CFU-TandPhenotypically Mature TCells.
￿
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FIGURE 3 .
￿
8-wk fetal tissue contained scattered TCRS1' cells that were CD45' and CD3' .
(A) CD45' cells in thorax of 8-wk tissue number 24. (B) Sequential 4 km tissue section in which
the CD45' cell indicated by arrow inA isTCRS1' as well . Arrowheads show CD45' cells that
were TCRS1- . (E) An autofluorescent rim of epithelium. (C)A rare cluster of CD3' cells of
8-wk thorax tissue number 24 beneath skin epithelium. (D)A sequential 4-pm section of the
identical area in which one of the CD3' cells (arrow) is TCRS1' . 400x .
sterile fetal liver cellsfrom 9.5, 10, and 12 .75 wk ofgestation were available for study
in vitro. First, we assayed unfractionated fetal liver cells for their ability to give rise
to myeloid (GM-CFU-C, CFU-GEMM), erythroid (BFU-E), andlymphoid (CFUT)
colonies in vitro. Fetal liver cells from these gestational ages all contained cells capable
of giving rise to lymphoid (CFUT) colonies, and as others have shown (43, 44),
erythroid and myeloid colonies (Table V) .1070
-, no cells positive in IF assay.
+ / - , <10 positive cells per 400 x field.
+ , 10-40 positive cells per 400 x field.
+ +, >50°Jo of all thymocytes positive .
* Reactivity of anti-CD4 antibodies with 8.5-wk thymus in double indirect IF assay identified
T200+ , Leu-M3', CD7- macrophages. In 9 .5-, 10-, 12.75-, and 14-wk thymuses, anti-CD4
antibodies reacted with thymocytes as well as with scattered thymic macrophages.
No hematopoietic cells were present in the 7-wk thymic rudiment .
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TABLE III
Phenotype of Thymocytes in Fetal Thymus
TABLE IV
Phenotype of Hematopoietic Cells in Fetal Liver
- , no cells seen positive in indirect IF assay.
+ / - , <I 0 positive cells seen per tissue section.
+ , >10 positive cells seen per tissue section .
' In tissues no. 48, 22, and 40, rare (0-2 cells/section) Leu4', OKT3 - cells were seen.
1 Identical results were obtained with the anti-Ti a, (i reagent BMA031 (not shown) .
4 In the 7-, 10-, and 12.5-wk fetal liver tissues, all CD4' cells were large pigment-containing
cells. Double IF experiments using fetal liver number 22 confirmed that CD7' cells were
CD4- , and that CD4' cells were both CD7- and Leu-M3' (i .e ., tissue macrophages and
Kupffer cells).
TABLE V
Growth of Hematopoietic Progenitors from Human Fetal Liver
* Fetal liver number 40 was either cultured in vitro after Ficoll-Hypaque purification of mononuclear cells,
or after panning separations performed using anti-Ig-coated plates for CD7' and CD7- populations, as
described in Materials and Methods. Data for CD7' and CD7- fetal liver number 40 cells represent the
mean of two separate experiments.
Tissue
number Gestational age
wk
CD45 CD7 CD2
Marker
CD3 CD8 CD1 CD4*
501 7
20 8.5 ++ ++ + +/- - - +
48 9.5 ++ ++ ++ ++ ++ + ++
2 10 ++ ++ ++ + ++ + ++
22 10 ++ ++ ++ ++ ++ ++ ++
40 12.75 ++ ++ ++ ++ ++ ++ ++
Fetal liver number Gestational age Cell suspension GM-CFU-C CFU-GEMM BFU-E CFU-T
wk Colonies/]()'' cells
48 9.5 Fetal liver 1,360 620 1,700 :320
22 10 Fetalliver 380 15 110 ND
40* 12.75 Fetal liver 103 18 6 6
40 12.75 CD7' fetal liver 145 35 0 130
40 12.75 CD7- fetal liver 90 125 100 0
Tissue
number Gestational age
wk
CD45 CD7 CD2 CD3
Marker*
TCR81 WT311 CD8 CDI CDO
50 7 + +/- - - - ND - - +
48 9.5 + + - - - - - - +
22 10 + + - - - - - - +
40 12.5 + + - - - - - - +HAYNES ET AL.
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To determine the phenotype of CFUT from CD7' fetal liver cells that prolifer-
ated in response to TCM and rIL-2, unfractionated fetal liver (cells number 48,
9 .5 wk), were stimulated for 15 d with TCM and 80 U AL-2, cytocentrifuge slide
preparations were made, and the cells were assayed in indirect IF assayfor reactivity
with the monoclonal antibodies listed in Table VI .
Unfractionated fresh fetal liver cells (number 48) at the time of culture were 3%
blast forms, and 92% erythroid, 1% lymphoid, 2% monocytoid, and 2%
megakaryocytoid lineages, as determined on Wright's-stained cytocentrifuge prepa-
rations. After culture for 15 d in TCM plus rIL-2, fetal liver cells (number 48) were
81% blast morphology, with the phenotype shown in Table VI. Whereas none of
the number 48 fetal liver cells were reactive with anti-CD8, WT31, or CD2 anti-
bodies before culture, 13-19% of cells were reactive with these T lineage-specific
reagents after 15 d.
Although these data demonstrated that cells within 9 .5-wk fetalliver can give rise
to cells of the T cell lineage, they did not address the question of whether CD7+
or CD7 - fetal cells could give rise to Tlineage cells. To address this question,
purified CD7+ and CD7 - populations were obtained from number 40 12.75-wk
fetalliver tissue using panning techniques (Tables V and VII). We found that freshly
isolated CD7' fetal liver cells were 71% blast forms, 27% erythrold, and 1117o
monocytoid forms, (Fig. 4 A). CD7' fetal liver cells were enriched for CFUT 20-
fold compared with fresh fetal liver cells (Table V), whereas CD7 - fresh fetal liver
cells [containing 11% blasts, 88% erythroid, and 1% monocytoid forms (Fig. 4 B)]
contained no CFUT (Table V). Importantly, both CD7' and CD7- fetal liver cells
contained cells capable of giving rise to CFU-GM and CFU-GEMM colonies under
the appropriate culture conditions (Table V) (Fig. 4, C and D).
Next, to determine the phenotype of cells in CFUT from CD7' fetal cells, CD7'
and CD7 - fetal liver cells from number 40 were cultured in the presence of TCM
plus 80 U rIL-2 for 10 d, cytocentrifuge preparations were made, and the cells were
assayed for reactivity with the monoclonal antibodies listed in Table VII.
We found that -40-50% of CD7', 12.75-wk fetal liver cells expressed CD2, CD3,
TABLE VI
Phenotype of 9.5-wk Unfractionated Fetal Liver Cells Stimulated
for 5 d with T Cell-conditioned Media and rII-2
Marker
￿
Positive cells
CD7
￿
24
CD2
￿
19
CD3
￿
15
CD4
￿
6
CD8
￿
14
CD1
￿
0
WT31
￿
13
TCR61
￿
1
CD25 (TAC)
￿
16
The percentage ofcells positive for each marker was determined by prepar-
ing acetone-fixed cytocentrifuge preparations and using these in indirect
IF assays with the indicated monoclonal antibodies .107 2
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TABLE VII
Phenotype of 12.5-wk Fetal Liver Cells Stimulated for 10 d
with T Cell-conditioned Media and rII-2
The percentage ofcells positive for each marker was determined by prepar-
ing acetone-fixed cytocentrifuge preparations and using these in indirect
IF assays with the indicated monoclonal antibodies. Data are the means
of two separate experiments using cells from fetal liver number 40. Anti-
CD4 and anti-CD8 antibodies were only used together in these experi-
ments to identify cells either CD4' or CD8' due to limited numbers of
cells.
CD4, or CD8, and WT31 antigens after 10 d in culture with TCM plus IL-2 (Fig.
4, E and F), whereas few CD7- fetal liver cells expressed these antigens under the
same culture conditions (Table VII and Fig. 4). At the end of 10 d in TCM plus
IL-2, CD7' cells were 59% lymphoblasts, and 5% myeloid, 33% mast cell or
monocytoid, and 6% megakaryocytoid morphologies. In contrast, CD7- fetal liver
cells, cultured under the same conditions, were 5% lymphoblasts, and 18% my-
eloid, 70% mast cell or monocytoid, and 3% megakaryocytoid morphologies (Fig. 4).
CD7' Cells from the 7-wk Upper Thorax Tissue Gave Rise to Tlineage Cells.
￿
To ad-
dress the question of whether fetal thorax CD7' cells could also give rise to cells
of the T cell lineage, fresh tissue from the thorax region of 7-wk fetal tissue from
number 46 was divided and half was preserved for frozen tissue sections and anal-
ysis in indirect IF assay (Table II). The other half was teased apart by mechanical
dissociation and cultured in TCM with rIL-2. After 4 d, clumps of proliferating
cells were seen, and by 14 d sufficient cells were present for analysis in IF assays
on a cytofluorograph. As seen in Fig. 5, whereas all CD7' cells in situ in the thorax
before culture were CD3 -, WT31 -, CD8 -, and CD2 - (Table II), the CD7' cells
that grew out from number 46 thorax were 57-94% positive for these T cell markers.
In double-label experiments using cytofluorography and directly labeled CD4 and
CD8 monoclonal antibodies, we found 6% ofcells from number 46 cultured in TCM
with rIL-2 were both CD4+ and CD8+ on day 14, while the remainder of the cells
reciprocally expressed either CD4 or CD8 (not shown).
Discussion
In this study, we show that CD7+, CD45+, CD2 -, CD3-, CD8 -, WT31 - ,
TCRS1 -, cells are present in fetal 7-wk yolk sac, thorax/neck, and liver before he-
matopoietic cell colonization of the epithelial thymic rudiment. Moreover, between
7 and 8.5 wk of gestation, CD7' cells are concentrated in neck and upper thorax
areas. Finally, we have shown that CD7' cells from thorax and fetal liver give rise
to T-lineage cells expressing CD8, CD4, CD2, CD3, and WT31 antigens.
Marker CD7' fetal liver
Positive cells
cells CD7- fetal liver cells
I
CD7 64 7
CD2 47 6
CD3 39 13
CD4 + CD8 35 9
CD1 0 0
WT31 48 3FIGURE 4.
￿
Hematopoietic cells isolated from human fetal liver . A . Blast morphology offreshly
isolated CD7' cells from 12.75-wk (number 40) fetal liver. B. Erythroid morphology ofCD7-
fetal liver number 40 cells. B, basophilic normoblast ; P, pronormoblasr N, polychomatophilic
normoblast ; R, fragmented red blood cell . CandD. CFU-GEMM colony derived from CD7'
fetal liver cells (C) and CD7- fetal liver cells (D) . E. Representative T cell colony grown in
TCM11L-2 from 10-wk fetal livernumber 22 . F . CD3' cells (wrows) from CFUT arising in cul-
tured purified CD7' fetal liver number 40 cells.1074
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RELATIVE FLUORESCENCE INTENSITY
F[GURE 5.
￿
Phenotype of cells grown from 7-wk fetal tissue number 46 after 15 din TCM plus
IL-2 . Panels show cytofluorograph analysis ofcells reacted in indirect IF assay with the indicated
reagents. Percent of cells reactive with each reagent were CD7, 91% ; CD2, 94% ; CD3, 93% ;
WT31, 85% ; CD4, 42%; CD8, 57% ; CD1, 0%; TAC, 72%. This population of cells were also
Bl, 1% ; L243 (MHC class II), 50%; My10, 1%; Mo-1, 14%; E5, 0% (not shown).
LeDourain et al. (1-3) have demonstrated that T cell precursors first home to the
avian epithelial thymic rudiment during early embryonic development . Using the
quail-chick hybrid system, it was shown that migration of T cell precursors from
yolk sac and bone marrow to the epithelial thymus occured in waves at defined periods
of time in thymic ontogeny (1-3). Champion et al. (6) have gone on to show that
during the receptive period of the avian thymus for homing T cell precursors, thymic
epithelial cells produce peptides of 1 and 4 kD that are chemotactic for T cell precursors.
Moore and Owen (7) in classic early studies on the development of the avian and
murine thymus observed lymphoid cells in and around the epithelial thymic rudi-
mentjust before and during the time ofhematopoietic cell colonization ofthe thymus.
The likely explanation of localization of CD7 + cells to the neck and upper thorax
at a defined point (7-8.5 wk) in human fetal gestation is that thorax CD7+ cells
represent a wave (or waves) of migration of T cell precursors to the human thymic
rudiment . Thus, in man, there appears to be a developmentally regulated window
of time at 7-8.5 wk gestation during which the migration of T cell precursors to
the epithelial thymus occurs.
In contrast to the work of Le Dourain et al. in the avian model, in which multiple
waves ofprecursors were observed entering the thymus at defined intervals, we have
only observed one possible wave of precursor cells at 7-8 wk of gestation. In this
regard it is important to note that at 7-8 wk the human thymus is poorly vascula-
rized, with only a few thin-walled capillaries present (41, 45). Moreover, we found
in the present study no CD7' cells in heart, aorta, or smaller thorax vessels in 7-
or 8-wk tissue. Thus, a potential reason for observing only one time period in which
CD7' cells are concentrated in thoracic mesenchyme may relate to initial coloni-
zation of the thymus occurring via migration of T cell precursors through tissue
rather than via thymic blood vessels. Le Douarin and Jotereau (1) found that lym-
phoid precursors were present in thymic rudiments of avian interspecific chimeras
L
CONTROL CD7 CD2
L..rA_
CD4 CD1 CD8
CD3 TACHAYNES ET AL.
￿
1075
before vascularization ofthe thymic rudiment. Once full vascularization ofthe thymus
occurs at 8-9 wk, then ingress of T cell precursors into the thymus likely occurs
via thymic vessels (42, 46).
In addition to demonstrating time- and location-dependent appearance of CD7+
cells in human fetal tissues, our studies have directly demonstrated that CD7 + cells
within fetal liver contain cells capable of CFU T formation (Table V), and that
CD7+ CFUT contain cells of the T lineage (Table VII). A large number of studies
have investigated the phenotype of human and murine T cell precursors from a va-
riety of sources (16, 47-57). Murine and human postnatal bone marrow (BM) T
cell precursors have been reported to be TdT + (47, 52) . Human postnatal BM T
cell precursors have been postulated to reside in the RFB-1+, CD7 +, TdT+ popula-
tion of cells (47, 52). RFB-1+, TdT+ cells in human fetal liver have also been postu-
lated to contain T cell precursors (54, 55). In postnatal human thymus, a population
of CD7+, CD2 -, CD3 -, CD4-, CD8-, WT31 - cells have been identified that are
germline in configuration for Tip genes and express cytoplasmic but not surface CD3
molecules (58). From these latter observations, Furley et al. (58) concluded that the
earliest stages of human intrathymic maturation are the expression of CD3 genes
in CD7+, CD2- cells, followed by Tip gene rearrangement and expression. In our
present studies, the observation of many fetal CD3 + cells that were neither WT31 +
(Tia, p+ ) nor TCR81 + (TiB + ) in several 7- and 8-wk tissues suggested that an anal-
ogous pathway of T cell maturation to that proposed by Furley et al. (58) occurs
during early human fetal ontogeny.
Whether CD3 expression can occur in T cell precursors in vivo before migration
to the thymus is at present unknown. In tissues number 35, 24, and 32, where scat-
tered CD3+ cells that were Tia, p- and TiS - . were present in thorax, thymic tissue
was not available for study to determine if thymic colonization by hematopoietic
cells had occurred. In tissue number 20 (8 .5 wk) we were able to show that thymic
colonization had occurred, and both the thymus and thorax contained scattered rare
CD3+ cells. In number 50 (7 wk) thymic colonization had not occurred, and no
CD3 + cells were seen in neck and upper thorax areas. Thus, based on these obser-
vations one would infer that CD3 expression by T cell precursors only occurs after
CD7+ T cell precursors have migrated through the thymus. However, the observa-
tion that 7-wk thorax cells and 9.5- and 12.75-wk fetal liver cells could be stimulated
to acquire reactivity with CD3 monoclonal antibodies without contact with thymic
epithelium suggests that CD3 expression may occur in CD7+ T cells before their
migration to the thymus. Thus, at the critical time of T cell precursor migration
to the thymus, there is either spillover of CD7+, CD3+ cells into thorax mesenchyme
from thymus, or the simultaneous onset in fetal thymus and in extrathymic tissues
of expression of CD3 genes in CD7+ cells.
It is of particular interest that expression of the CD7 antigen is the earliest marker
of the T lineage in man. While the function of the CD7 molecule is not yet known,
Jung et al. (59) have described a case of severe combined immunodeficiency disease
in which the T cells present were deficient in CD7 expression. In this patient, T
cell proliferative responses to mitogens were abnormal and IL-2 expression on T
cells was deficient. The authors proposed that CD7 deficiency in this patient was
related to a defect in T cell precursors, and that the CD7 molecule plays an impor-
tant role in early lymphoid development (59).1076
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The nature of the full differentiating capacity of the CD7+ fetal liver cell remains
to be fully explored. The data in Table V suggest that in addition to containing T
cell precursors, the CD7+ subset contains cells capable of forming CFU-GM and
CFU-GEMM colonies. Data from two otherstudies support the notion that the mul-
tipotent nature of CD7' fetal liver cells may indeed reflect the expression of the
CD7 molecule on pluripotent stem cells. First, we have recently shown that CD7',
CD4-, CD8 - cells from normal human postnatal thymus contain cells that are
pluripotent, in that they give rise to CFU-GM and GFU-GEMM colonies in vitro
with appropriate stimuli, yet proliferate and remain CD4- and CD8- in the pres-
ence of thymic epithelial cells and IL-2 (60, 61). Second, it has been shown that malig-
nancies of clonal CD7', CD4-, CD8 -, CD3- cells occur, and are capable of pluripo-
tent differentiation both in vitro and in vivo (60, 62, 63) .
The ability to identify T cell precursors in fetal tissues using antibodies against
the CD7 surface antigen has important ramifications. First, the presence of com-
paratively large numbers of CD7' cells in the thorax of 7-8-wk fetal tissues now
provides a source of these important cells for growth and isolation of clonal popula-
tions of T cell precursors and their progeny. Second, the demonstration of large
numbers of CD7' cells in fetal thorax at 7-8 wk suggests that fetal thorax tissue
may be a useful source of T cell precursors for use in therapuetic transplantation
into patients with forms of human cellular immunodeficiency diseases.
Summary
During early fetal development, T cell precursors home from fetal yolk sac and
liver to the epithelial thymic rudiment . From cells that initially colonize the thymus
arise mature T cells that populate T cell zones of the peripheral lymphoid system.
Whereas colonization of the thymus occurs late in the final third of gestation in the
mouse, in birds and humans the thymus is colonized by hematopoietic stem cell
precursors during the first third of gestation .
Using a large series of early human fetal tissues and a panel of monoclonal anti-
bodies that includes markers of early T cells (CD7, CD45), we have studied the im-
munohistologic location and differentiation capacity of CD45', CD7+ cells in
human fetal tissues. We found that before T cell precursor colonization of the thymus
(7-8 wk of gestation), CD7' cells were present in yolk sac, neck, upper thorax, and
fetal liver, and were concentrated in mesenchyme throughout the upper thorax and
neck areas . By 9.5 wk of gestation, CD7' cells were no longer present in upper
thorax mesenchyme but rather were localized in the lymphoid thymus and scattered
throughout fetal liver. CD7', CD2 - , CD3 - , CD8 - , CD4 - , WT31 - cells in thorax
and fetal liver, when stimulated for 10-15 d with T cell-conditioned media and rIL-
2, expressed CD2, CD3, CD4, CD8, and WT31 markers of the T cell lineage.
Moreover, CD7' cells isolated from fetal liver contained all cells in this tissue
capable of forming CFUT colonies in vitro. These data demonstrate that T cell
precursors in early human fetal tissues can be identified using a mAb against the
CD7 antigen. Moreover, the localization of CD7' T cell precursors to fetal upper
thorax and neck areas at 7-8 .5 wk of fetal gestation provides strong evidence for
a developmentally regulated period in man in which T cell precursors migrate to
the epithelial thymic rudiment.The authors thank Drs. Michael Brenner, Robert Evans, John Fabre, John Hansen, Roger
Kurrle, Andrew McMichael, Ellis Reinherz, Henry Sun, Wil Tax, Robert Todd, Thomas
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